Skip to main content
Clinical Trials/NCT04499300
NCT04499300
Completed
Not Applicable

Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age

Murielle Surquin1 site in 1 country50 target enrollmentJune 9, 2020
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Murielle Surquin
Enrollment
50
Locations
1
Primary Endpoint
Demographic data
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ranging from asymptomatic forms to more commonly critical pulmonary forms called "Acute Respiratory Distress Syndrome". The elderly population is more at risk for this infection due to the senescence of the immune system, co-morbidities and poly medications. They also often present a greater state of fragility.

This study aims to report the epidemiology of the first 50 patients over 90 years of age hospitalized within the CHU Brugmann hospital.

Registry
clinicaltrials.gov
Start Date
June 9, 2020
End Date
November 23, 2020
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Murielle Surquin

Head of geriatry department

Brugmann University Hospital

Eligibility Criteria

Inclusion Criteria

  • Be over 90 years of age on the date of admission to CHU Brugmann Hospital
  • Have a SARS Cov2 infection proven by antigen or RT-PCR on smear and / or typical imaging regardless of the clinical manifestation
  • Have been hospitalized at CHU Brugmann between 03/01/2020 and 05/10/2020

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Demographic data

Time Frame: 5 minutes

Age, sex, ethnicity

CK

Time Frame: 5 minutes

CK at hospital admission or first recorded

Troponin

Time Frame: 5 minutes

Troponin at hospital admission or first recorded

Number of pulmonary lobes affected

Time Frame: 5 minutes

Number of pulmonary lobes affected

Comorbidities

Time Frame: 5 minutes

Smoking, Obesity, Diabetes, Arterial hypertension, Coronary pathology, Cerebrovascular disease, chronic renal failure, chronic obstructive pulmonary disease, Neoplasia, Autoimmune disease, Chronic liver disease

Gasometry

Time Frame: 5 minutes

Vital signs at hospital admission: Gasometry

Blood count

Time Frame: 5 minutes

Blood count at hospital admission or first recorded

Coagulation

Time Frame: 5 minutes

Coagulation at hospital admission or first recorded

Renal function

Time Frame: 5 minutes

Renal function at hospital admission or first recorded

Albumin

Time Frame: 5 minutes

Albumin at hospital admission or first recorded

Ionogram

Time Frame: 5 minutes

Ionogram at hospital admission or first recorded

NTproBNP

Time Frame: 5 minutes

NTproBNP at hospital admission or first recorded

Length of ICU Stay

Time Frame: 5 minutes

Length of ICU Stay

Procalcitonin

Time Frame: 5 minutes

Procalcitonin at hospital admission or first recorded

Treatments

Time Frame: 5 minutes

Under Chronic corticosteroid therapy or Immunosuppressive therapy

Hypotension

Time Frame: 5 minutes

Vital signs at hospital admission: Hypotension

Infectious data

Time Frame: 5 minutes

Contact with confirmed covid person before admission, lives in a retirement home with other cases, Initial bacterial or viral co-infection, Bacterial or viral co-infection during the hospital stay

D-dimers at hospital admission or first recorded

Time Frame: 5 minutes

D-dimers

Status at hospital exit

Time Frame: 5 minutes

One of the following choices: death, went back home, went back to a retirement home, was placed in a revalidation unit.

Treatment received

Time Frame: 5 minutes

Hydroxychloroquine or Azithromycin

Liver function

Time Frame: 5 minutes

Liver function at hospital admission or first recorded

Fibrinogen

Time Frame: 5 minutes

Fibrinogen at hospital admission or first recorded

Fever

Time Frame: 5 minutes

Vital signs at hospital admission: Fever

Hypoxemia

Time Frame: 5 minutes

Vital signs at hospital admission: Hypoxemia

Tachycardia

Time Frame: 5 minutes

Vital signs at hospital admission:Tachycardia

Mortality

Time Frame: 5 minutes

28-day mortality after PCR / CT scan / diagnosis

Cumulative Illness Rating Scale-Geriatric (CIRS-G)

Time Frame: 5 minutes

CIRS-G quantifies burden of disease in elderly patients (comorbidity scale). Higher scores indicate higher severity (maximum score = 56 points).

Signs and symptoms

Time Frame: 5 minutes

Presence and date of first apparition: Fever, Cough, Dyspnea, Chest pain, Nausea or vomiting, Diarrhea, Fatigue, Anosmia, ageusia, inappetence, Confusion, Fall, Fracture

CRP

Time Frame: 5 minutes

CRP at hospital admission or first recorded

Ferritin

Time Frame: 5 minutes

Ferritin at hospital admission or first recorded

Biology - highest rate

Time Frame: 5 minutes

Highest rate of CRP, D-Dimers, Urea, Creatinin, Fibrinogen, CK, Troponins

Biology - lowest rate

Time Frame: 5 minutes

Lowest rate of hemoglobin, platelets, leucocytes, lymphocytes, albumin, Na+, K+

Percentage of pulmonary involvement on chest CT scan

Time Frame: 5 minutes

Percentage of pulmonary involvement on chest CT scan

Type of lesions

Time Frame: 5 minutes

Type of lesions as reflected on the CT scan images: 'Ground glass' or 'Crazy paving'

Need for oxygenotherapy

Time Frame: 5 minutes

Need for oxygenotherapy (yes/no)

Means of ventilation

Time Frame: 5 minutes

Means of ventilation

Study Sites (1)

Loading locations...

Similar Trials